rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2007-8-9
|
pubmed:abstractText |
The purpose of our study was to evaluate the effects of a new reimbursement rule for antihypertensive medication that made thiazides mandatory first-line drugs for newly treated, uncomplicated hypertension. The objective of the new regulation was to reduce drug expenditures.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1549-1676
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e232
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17622192-Antihypertensive Agents,
pubmed-meshheading:17622192-Drug Utilization,
pubmed-meshheading:17622192-Humans,
pubmed-meshheading:17622192-Hypertension,
pubmed-meshheading:17622192-Insurance, Health, Reimbursement,
pubmed-meshheading:17622192-Norway,
pubmed-meshheading:17622192-Physician's Practice Patterns,
pubmed-meshheading:17622192-Thiazides,
pubmed-meshheading:17622192-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
The effects of mandatory prescribing of thiazides for newly treated, uncomplicated hypertension: interrupted time-series analysis.
|
pubmed:affiliation |
Norwegian Knowledge Centre for the Health Services, Oslo, Norway. atle.fretheim@nokc.no
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|